On March 17, 2014, Cardium Therapeutics, Inc. changed its name to Taxus Cardium Pharmaceuticals Group Inc.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% | -.--% | -.--% |
2022 | Gene Biotherapeutics, Inc. Auditor Raises 'Going Concern' Doubt | CI |
2021 | Gene Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020 | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 64 | |
+49.10% | 5.69TCr | |
+39.69% | 4.03TCr | |
-7.51% | 3.93TCr | |
-5.96% | 2.84TCr | |
+12.17% | 2.64TCr | |
-18.24% | 1.94TCr | |
+30.33% | 1.25TCr | |
+24.61% | 1.22TCr | |
-1.54% | 1.21TCr |
- Stock Market
- Equities
- CRXM Stock
- News Gene Biotherapeutics, Inc.
- Cardium Therapeutics, Inc. has Changed its Name to Taxus Cardium Pharmaceuticals Group Inc